There are 317 resources available
Understanding the biology of TNBC: Where are we in 2019?
Presenter: Jorge Reis-Filho
Session: Metastatic breast cancer: TNBC
Resources:
Presentation
Webcast
Who does NOT need PARP inhibition?
Presenter: Giuseppe Curigliano
Session: Metastatic breast cancer: TNBC
Resources:
Presentation
Webcast
Is chemotherapy becoming obsolete in TNBC?
Presenter: Alexandru Eniu
Session: Metastatic breast cancer: TNBC
Resources:
Presentation
Webcast
Changing paradigms in sequencing of treatment modalities in early stage breast cancer
Presenter: Nadia Harbeck
Session: Innovative treatment across subtypes
Resources:
Presentation
Webcast
The role of metastatic tumor profiling and targeted therapies
Presenter: Lajos Pusztai
Session: Innovative treatment across subtypes
Resources:
Presentation
Webcast
Emerging role of antibody-drug conjugates
Presenter: Hope Rugo
Session: Innovative treatment across subtypes
Resources:
Presentation
Webcast
miRNA expression profiles in BRCA1-associated breast cancers reveal upregulation of specific miRNAs in tumors lacking a clear second hit in a large proportion of the tumour
Presenter: Mattias Van Heetvelde
Session: Mini oral session 2
Resources:
Abstract
Presentation
Webcast
Observation of DCIS
Presenter: Emiel Rutgers
Session: The changing paradigm for breast cancer surgery
Resources:
Presentation
Webcast
Sentinel lymph node biopsy after neoadjuvant therapy: Where do we go from there?
Presenter: Isabel Rubio
Session: The changing paradigm for breast cancer surgery
Resources:
Presentation
Webcast
Oncoplastic breast conservative surgery for multicentric tumors: No more exclusion criteria for clinical trials
Presenter: Tibor Kovacs
Session: The changing paradigm for breast cancer surgery
Resources:
Presentation
Webcast